These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

992 related articles for article (PubMed ID: 18384087)

  • 21. Prebiotics and Probiotics in Inflammatory Bowel Disease: Where are we now and where are we going?
    Naseer M; Poola S; Ali S; Samiullah S; Tahan V
    Curr Clin Pharmacol; 2020; 15(3):216-233. PubMed ID: 32164516
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of a probiotic preparation (VSL#3) on induction and maintenance of remission in children with ulcerative colitis.
    Miele E; Pascarella F; Giannetti E; Quaglietta L; Baldassano RN; Staiano A
    Am J Gastroenterol; 2009 Feb; 104(2):437-43. PubMed ID: 19174792
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current dilemmas in the management of inflammatory bowel disease.
    Rutgeerts P
    Eur J Surg Suppl; 2002; (587):58-61. PubMed ID: 16144202
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Probiotics, prebiotics, synbiotics: ecological treatment for inflammatory bowel disease?
    Marteau P
    Gut; 2006 Dec; 55(12):1692-3. PubMed ID: 17124152
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inflammatory bowel disease, gut bacteria and probiotic therapy.
    Reiff C; Kelly D
    Int J Med Microbiol; 2010 Jan; 300(1):25-33. PubMed ID: 19800289
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Crohn disease, ulcerative colitis. When bacteria attack the intestinal wall....].
    Duchmann R; Lochs H; Kruis W
    MMW Fortschr Med; 1999 Dec; 141(51-52):48-51. PubMed ID: 10949626
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Probiotics and prebiotics in Crohn's disease therapies.
    Lichtenstein L; Avni-Biron I; Ben-Bassat O
    Best Pract Res Clin Gastroenterol; 2016 Feb; 30(1):81-8. PubMed ID: 27048899
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Probiotics in the treatment of human inflammatory bowel diseases: update 2011.
    Meijer BJ; Dieleman LA
    J Clin Gastroenterol; 2011 Nov; 45 Suppl():S139-44. PubMed ID: 21992953
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Probiotics--should we change the treatment strategy for pouchitis?].
    Klinge LG; Kjeldsen J
    Ugeskr Laeger; 2006 Oct; 168(41):3516-8. PubMed ID: 17059804
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Probiotics, prebiotics, and synbiotics.
    de Vrese M; Schrezenmeir J
    Adv Biochem Eng Biotechnol; 2008; 111():1-66. PubMed ID: 18461293
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modulating the microbiota in inflammatory bowel diseases: prebiotics, probiotics or faecal transplantation?
    Verbeke KA; Boesmans L; Boets E
    Proc Nutr Soc; 2014 Nov; 73(4):490-7. PubMed ID: 24969143
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomized controlled trial on the efficacy of synbiotic versus probiotic or prebiotic treatment to improve the quality of life in patients with ulcerative colitis.
    Fujimori S; Gudis K; Mitsui K; Seo T; Yonezawa M; Tanaka S; Tatsuguchi A; Sakamoto C
    Nutrition; 2009 May; 25(5):520-5. PubMed ID: 19201576
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Review article: the intestinal lumen as a therapeutic target in inflammatory bowel disease.
    Gassull MA
    Aliment Pharmacol Ther; 2006 Oct; 24 Suppl 3():90-5. PubMed ID: 16961752
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Probiotics in Inflammatory Bowel Disease.
    Abraham BP; Quigley EMM
    Gastroenterol Clin North Am; 2017 Dec; 46(4):769-782. PubMed ID: 29173520
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systematic review of randomized controlled trials of probiotics, prebiotics, and synbiotics in inflammatory bowel disease.
    Ghouri YA; Richards DM; Rahimi EF; Krill JT; Jelinek KA; DuPont AW
    Clin Exp Gastroenterol; 2014; 7():473-87. PubMed ID: 25525379
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intestinal microbiota, probiotics and prebiotics in inflammatory bowel disease.
    Orel R; Kamhi Trop T
    World J Gastroenterol; 2014 Sep; 20(33):11505-24. PubMed ID: 25206258
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibiotics, probiotics and prebiotics in IBD.
    Bernstein CN
    Nestle Nutr Inst Workshop Ser; 2014; 79():83-100. PubMed ID: 25227297
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Manipulation of intestinal microbial flora for therapeutic benefit in inflammatory bowel diseases: review of clinical trials of probiotics, pre-biotics and synbiotics.
    Heilpern D; Szilagyi A
    Rev Recent Clin Trials; 2008 Sep; 3(3):167-84. PubMed ID: 18782075
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Probiotics in experimental and human inflammatory bowel disease: discussion points.
    Pagnini C; Cominelli F
    Dig Liver Dis; 2006 Dec; 38 Suppl 2():S270-3. PubMed ID: 17259089
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gut microflora: a new target for therapeutic approaches in inflammatory bowel disease.
    Mitsuyama K; Sata M
    Expert Opin Ther Targets; 2008 Mar; 12(3):301-12. PubMed ID: 18269340
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 50.